Karin Eastham

Director

Karin Eastham (Director) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Veracyte, Inc. (VCYT). The largest single filing was $872K of VCYT (19,200 sh across 2 lots, as filed), executed Dec 5 2025.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 3 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$1.4M

shares × price, as filed

Last traded

Jun 18

Filed Jun 22

Median ADV $55.3M across their filed names

Open performance→

Volume by month

Buys $0 Sells $2.5M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 3 filings

Sector per market data · by filing · past 12 months

Most traded names

VCYT

Veracyte, Inc. VCYT · 0 buys · 6 sells 6 filings

Recent filings

VCYTSALE Veracyte, Inc. View filing → $169K
3,200 sh × $52.78
Exec Jun 18
Filed Jun 22 · 5:30 PM ET VCYTSALE Veracyte, Inc. View filing → $872K
19,200 sh across 2 lots
Exec Dec 5 2025
Filed Dec 8 2025 · 5:30 PM ET VCYTSALE Veracyte, Inc. View filing → $387K
9,674 sh × $40.02
Exec Nov 5 2025
Filed Nov 7 2025 · 5:30 PM ET VCYTSALE Veracyte, Inc. View filing → $122K
4,590 sh × $26.66
Exec Jun 13 2025
Filed Jun 17 2025 · 5:30 PM ET VCYTSALE Veracyte, Inc. View filing → $403K
10,000 sh across 2 lots
Exec Jan 2 2025
Filed Jan 6 2025 · 5:30 PM ET VCYTSALE Veracyte, Inc. View filing → $506K
13,131 sh across 2 lots
Exec Nov 19 2024
Filed Nov 21 2024 · 5:30 PM ET